142 related articles for article (PubMed ID: 15166281)
21. [Comparison of polyethylene glycol conjugated asparaginase and L-asparaginase for treatment of childhood acute lymphoblastic leukemia].
Cooperation Group of Phase II Clinical Trial of PEG-Asp
Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):29-33. PubMed ID: 18512312
[TBL] [Abstract][Full Text] [Related]
22. Pyomyositis during induction chemotherapy for acute lymphoblastic leukemia.
Kao KL; Hung GY; Hwang B
J Chin Med Assoc; 2006 Apr; 69(4):184-8. PubMed ID: 16689202
[TBL] [Abstract][Full Text] [Related]
23. Diabetes mellitus and pancreatitis as a complication of L-asparaginase therapy.
Charan VD; Desai N; Singh AP; Choudhry VP
Indian Pediatr; 1993 Jun; 30(6):809-10. PubMed ID: 8132268
[No Abstract] [Full Text] [Related]
24. Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx.
Thurnher D; Kletzmayr J; Formanek M; Quint C; Czerny C; Burian M; Kornek G
Oncology; 2001; 61(2):143-6. PubMed ID: 11528253
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic paracentesis in an acute lymphoblastic leukemia child without characteristic symptoms of pancreatitis.
Chao YH; Sheu JN; Chen SM; Wu KH
J Pediatr Hematol Oncol; 2013 Jan; 35(1):e47. PubMed ID: 22858569
[No Abstract] [Full Text] [Related]
26. Lethal systemic herpes simplex virus type 1 infection during chemotherapy for acute lymphoblastic leukaemia.
Wirth K; Fetscher S; Neumann-Haefelin D; Herget GW; Lübbert M
Br J Haematol; 1999 Jan; 104(1):197-8. PubMed ID: 10027735
[No Abstract] [Full Text] [Related]
27. Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
Yamamoto M; Hori T; Igarashi K; Iesato K; Saito M; Miyanishi K; Kikuchi N; Fujita H; Tsutsumi H
Int J Hematol; 2018 Apr; 107(4):390-391. PubMed ID: 29181701
[No Abstract] [Full Text] [Related]
28. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
Nachman J; Sather HN; Gaynon PS; Lukens JN; Wolff L; Trigg ME
J Clin Oncol; 1997 Jun; 15(6):2222-30. PubMed ID: 9196134
[TBL] [Abstract][Full Text] [Related]
29. Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1.
Mauro M; Saggiorato G; Sartori MT; Gallo G; De Bortoli M; Bonetti E; Zaccaron A; Vitale V; Balter R; Chinello M; Cesaro S
Pediatr Blood Cancer; 2018 Jun; 65(6):e26963. PubMed ID: 29350496
[TBL] [Abstract][Full Text] [Related]
30. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
[TBL] [Abstract][Full Text] [Related]
31. Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy.
Saviola A; Luppi M; Potenza L; Morselli M; Bresciani P; Ferrari A; Riva G; Torelli G
Eur J Haematol; 2004 Jan; 72(1):71-2. PubMed ID: 14962268
[TBL] [Abstract][Full Text] [Related]
32. Haemolytic uraemic syndrome in a patient with lung cancer: further evidence for a toxic interaction between mitomycin-C and tamoxifen.
Ellis PA; Luckitt J; Treleaven J; Smith IE
Clin Oncol (R Coll Radiol); 1996; 8(6):402-3. PubMed ID: 8973862
[No Abstract] [Full Text] [Related]
33. Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukemia.
Hough R; Chetwood A; Sinfield R; Welch J; Vora A
J Pediatr Hematol Oncol; 2005 Feb; 27(2):67-72. PubMed ID: 15701979
[TBL] [Abstract][Full Text] [Related]
34. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
[TBL] [Abstract][Full Text] [Related]
35. An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia.
Kaspers GJL; Niewerth D; Wilhelm BAJ; Scholte-van Houtem P; Lopez-Yurda M; Berkhof J; Cloos J; de Haas V; Mathôt RA; Attarbaschi A; Baruchel A; de Bont ES; Fagioli F; Rössig C; Klingebiel T; De Moerloose B; Nelken B; Palumbo G; Reinhardt D; Rohrlich PS; Simon P; von Stackelberg A; Zwaan CM
Br J Haematol; 2018 May; 181(4):523-527. PubMed ID: 29676440
[TBL] [Abstract][Full Text] [Related]
36. Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis.
Ridola V; Buonuomo PS; Maurizi P; Putzulu R; Annunziata ML; Pietrini D; Riccardi R
Pediatr Blood Cancer; 2008 Feb; 50(2):378-80. PubMed ID: 16883590
[TBL] [Abstract][Full Text] [Related]
37. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.
Ronghe M; Burke GA; Lowis SP; Estlin EJ
Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
39. Parotid mucoepidermoid carcinoma following chemotherapy for childhood acute lymphoblastic leukemia.
Sandoval C; Jayabose S
Pediatr Hematol Oncol; 2001; 18(3):217-20. PubMed ID: 11293291
[TBL] [Abstract][Full Text] [Related]
40. Haemolytic-uraemic syndrome after treatment with metronidazole.
Powell HR; Davidson PM; McCredie DA; Phair P; Walker RG
Med J Aust; 1988 Aug; 149(4):222-3. PubMed ID: 3173180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
